Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Pocketsundialon Jan 03, 2018 3:52pm

48 Views

Post# 27273711

RE:RE:So how about that strong support in the mid .020,s

Looks like a big profit day, first of the year I bet. Even isodiols gain this year are all nearly erased so I'm not worried, especially with this support.

Alyon90 wrote:
that is nice to see....it is a little baffling that so many shares traded but being held in place. Doing the same thing it did at the teens just with a wider margin. Wonder if something is actually brewing after the Kurd news that is.

Bullboard Posts

Canadian government to fund Electric Royalties portfolio property